LP-003获批上市，从临床资产变成商业化资产，则有望直接推动天辰生物从“零收入未盈利”到“商业化验证”的估值切换，进而加速其场内短线结构与量价表现的改善。9月7日获纳入港股通名单后，天辰生物-B(01779)股价走出了一段明显的下跌行情。9月7日当 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results